Operationalizing High-Value Specialty Care: A Formula for Measuring Value Variation

Despite sustained growth in health care spending, value measurement in specialty care remains fragmented. Health systems typically evaluate cost and quality separately, limiting their ability to determine whether greater resource utilization produces proportional improvements in patient outcomes. Although episode-based payment models have reduced spending, they have largely focused on utilization and complications rather than patient-reported improvement or procedural-level value. Incremental cost-effectiveness ratios (ICERs) are traditionally used to compare the additional cost and benefit of competing interventions to inform population-level coverage and resource allocation decisions. However, conventional ICER applications rely on payer costs, generic health status measures, and lifetime follow-up, making them less suitable for operational decision-making within health systems. In this article, the authors describe a specialty-specific application of cost-effectiveness principles that support operational value assessment in procedural care. Rather than applying a traditional ICER, this approach uses a cost-per-outcome ratio that integrates health system costs with specialty-specific patient-reported outcome measures (PROMs) to benchmark value across comparable procedures. Costs are derived from internal health system data, enabling evaluation of variation in implant selection, supply utilization, and operative practice, while outcomes are measured using procedure-specific PROMs over clinically meaningful follow-up intervals. The authors demonstrate this framework with use of data from 623 primary total knee arthroplasty (TKA) procedures performed across a multicenter health system. Intraoperative supply costs varied more than threefold, whereas patient-reported improvement as measured with the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) demonstrated substantially less variation. Higher intraoperative spending was not associated with greater patient-reported improvement. Operationalizing a specialty-specific value formula by expressing value as the cost required to achieve 1 unit of patient-reported improvement revealed nearly sixfold variation across surgeons, driven primarily by differences in resource utilization rather than clinical outcomes. By integrating cost and patient outcomes into a single operational metric, this framework enables health systems to identify unwarranted variation, evaluate new technologies, support episode-based payment models such as the U.S. Centers for Medicare and Medicaid Services (CMS)'s Transforming Episode Accountability Model (TEAM), and engage clinicians in transparent, evidence-based discussions regarding value. As health systems continue to expand PROM collection and patient-level costing capabilities, operational value measurement offers a practical pathway for improving resource stewardship while maintaining patient-centered outcomes.

Authors

Institutions

Publication Details

Journal
NEJM Catalyst
Published
2026-11-18
DOI
https://doi.org/10.1056/cat.26.0113
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Operationalizing High-Value Specialty Care: A Formula for Measuring Value Variation

Charles S. Day, Meet Patel, David R. Nerenz, Alex Lindahl et al.
1 links
NEJM Catalyst
Health Systems, Economic Evaluations, Quality of Life
article

Operationalizing High-Value Specialty Care: A Formula for Measuring Value Variation

Charles S. Day, Meet Patel, David R. Nerenz, Alex Lindahl, Sydney Huston
article en

Abstract

Despite sustained growth in health care spending, value measurement in specialty care remains fragmented. Health systems typically evaluate cost and quality separately, limiting their ability to determine whether greater resource utilization produces proportional improvements in patient outcomes. Although episode-based payment models have reduced spending, they have largely focused on utilization and complications rather than patient-reported improvement or procedural-level value. Incremental cost-effectiveness ratios (ICERs) are traditionally used to compare the additional cost and benefit of competing interventions to inform population-level coverage and resource allocation decisions. However, conventional ICER applications rely on payer costs, generic health status measures, and lifetime follow-up, making them less suitable for operational decision-making within health systems. In this article, the authors describe a specialty-specific application of cost-effectiveness principles that support operational value assessment in procedural care. Rather than applying a traditional ICER, this approach uses a cost-per-outcome ratio that integrates health system costs with specialty-specific patient-reported outcome measures (PROMs) to benchmark value across comparable procedures. Costs are derived from internal health system data, enabling evaluation of variation in implant selection, supply utilization, and operative practice, while outcomes are measured using procedure-specific PROMs over clinically meaningful follow-up intervals. The authors demonstrate this framework with use of data from 623 primary total knee arthroplasty (TKA) procedures performed across a multicenter health system. Intraoperative supply costs varied more than threefold, whereas patient-reported improvement as measured with the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) demonstrated substantially less variation. Higher intraoperative spending was not associated with greater patient-reported improvement. Operationalizing a specialty-specific value formula by expressing value as the cost required to achieve 1 unit of patient-reported improvement revealed nearly sixfold variation across surgeons, driven primarily by differences in resource utilization rather than clinical outcomes. By integrating cost and patient outcomes into a single operational metric, this framework enables health systems to identify unwarranted variation, evaluate new technologies, support episode-based payment models such as the U.S. Centers for Medicare and Medicaid Services (CMS)'s Transforming Episode Accountability Model (TEAM), and engage clinicians in transparent, evidence-based discussions regarding value. As health systems continue to expand PROM collection and patient-level costing capabilities, operational value measurement offers a practical pathway for improving resource stewardship while maintaining patient-centered outcomes.

NEJM CatalystVol. 7(12)
Henry Ford Health System (US), Wayne State University (US), Henry Ford Hospital (US), Corewell Health William Beaumont University Hospital (US), Beaumont Hospital, Troy (US), Michigan State University (US)
Good health and well-being
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon